UNSPSC 85222602: Diagnosis of rhinocerebral mucormycosis

This classification denotes the group of activities that yields a diagnosis of Rhinocerebral mucormycosis. Rhinocerebral mucormycosis is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as a four digit category under code B46. 1

UNSPSC 85222602 Diagnosis of rhinocerebral mucormycosis is a Commodity code that shows minimal recent procurement activity directly aligned with its nominal scope. The code appears to map to specialized infectious disease diagnostic services, yet the three recent state and local solicitations posted under it—a diagnostic imaging PACS system, special education contracted services, and temporary health professional staffing—do not reflect diagnostic work specific to rhinocerebral mucormycosis or mycological infection testing. The mismatch suggests either broad tagging by procurement offices or misalignment between the code assignment and actual service delivery. When purchasing does occur under this code, state and local health systems and school districts appear to be the primary users, though the recent opportunities pool does not support a reliable characterization of issuing-body patterns or spending concentration.

The recent opportunities span California and Texas. San Mateo Medical Center (San Mateo County, California) posted an RFP for enterprise-grade diagnostic imaging PACS infrastructure due October 21, 2026, which supports multiple imaging modalities but does not explicitly address microbiology or infectious disease diagnostics. Birdville Independent School District (northeast Tarrant County, Texas) solicited special education contracted services, including diagnostician roles, due October 21, 2026—a services category orthogonal to the code's stated focus. The County of Santa Clara Health System (California) posted a qualification vehicle for temporary health professional staffing across 13 ancillary clinical categories due October 7, 2026, including diagnostic imaging and therapy services but no explicit microbiology or infectious disease diagnostics. The code warrants closer review of actual procurement intent; the recent activity does not support a pursue recommendation based on rhinocerebral mucormycosis diagnostics as the buying driver.